In vitro Characterization of a small molecule inhibitor of the alanine serine cysteine transporter ‐1 (SLC7A10)
- 10 December 2013
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 129 (2), 275-283
- https://doi.org/10.1111/jnc.12618
Abstract
NMDA receptor hypofunction is hypothesized to contribute to cognitive deficits associated with schizophrenia. Since direct activation of NMDA receptors is associated with serious adverse effects, modulation of the NMDA co-agonists, glycine or D-serine, represents a viable alternative therapeutic approach. Indeed, clinical trials with glycine and D-serine have shown positive results, although concerns over toxicity related to the high-doses required for efficacy remain. Synaptic concentrations of D-serine and glycine are regulated by the amino acid transporter alanine serine cysteine transporter-1 (asc-1). Inhibition of asc-1 would increase synaptic D-serine and possibly glycine, eliminating the need for high-dose systemic D-serine or glycine treatment. In this manuscript, we characterize Compound 1 (BMS-466442), the first known small molecule inhibitor of asc-1. Compound 1 selectively inhibited asc-1 mediated D-serine uptake with nanomolar potency in multiple cellular systems. Moreover, Compound 1 inhibited asc-1 but was not a competitive substrate for this transporter. Compound 1 is the first reported selective inhibitor of the asc-1 transporter and may provide a new path for the development of asc-1 inhibitors for the treatment of schizophrenia.Keywords
Funding Information
- Bristol-Myers Squibb Research Laboratories Wallingford, CT
This publication has 33 references indexed in Scilit:
- Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic SchizophreniaCNS Drugs, 2011
- Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent mannerNeuropharmacology, 2011
- High dose D-serine in the treatment of schizophreniaSchizophrenia Research, 2010
- Cellular distribution of the neutral amino acid transporter subtype ASCT2 in mouse brainJournal of Neurochemistry, 2008
- Evidence from gene knockout studies implicates Asc‐1 as the primary transporter mediating d‐serine reuptake in the mouse CNSEuropean Journal of Neuroscience, 2007
- Evaluation of oxidative stress in d-serine induced nephrotoxicityToxicology, 2007
- Molecular determinants of D‐serine‐mediated gliotransmission: From release to functionGlia, 2006
- d-Serine-induced nephrotoxicity: possible interaction with tyrosine metabolismToxicology, 2004
- Double-Blind, Placebo-Controlled, Crossover Trial of Glycine Adjuvant Therapy for Treatment-Resistant SchizophreniaThe British Journal of Psychiatry, 1996
- NMDA receptor function and human cognition: The effects of ketamine in healthy volunteersNeuropsychopharmacology, 1996